Medeonföretag

Abarceo Pharma AB

Abarceo Pharma is developing a small molecule technology platform for the treatment of mitochondrial dysfunction, with an initial focus on T2D.

KONTAKT
CEO Kristian Hansen
T +45 41704838
E kristian.hansen@abarceo.com
W www.abarceo.se

ADDRESS
Abarceo Pharma AB
Medeon Science Park
SE-205 12 Malmö

MEDEON IS AN IMPORTANT LIFE SCIENCE NODE WITH ITS CENTRAL LOCATION AND SPECIFIC NETWORKS, OFFERING ONE OF THE ÖRESUND REGION'S BEST GROWTH ENVIRONMENTS FOR COMPANIES. MEDEON PROMOTES INTERCHANGE BETWEEN THE ACADEMIC WORLD, PUBLIC SECTOR AND INDUSTRY.

Catrine Pauckstadt
Communications Manager

More about us